Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Cancer Research and Clinical Oncology|May 18, 2019
Safety and efficacy of aspirin for primary prevention of cancer: a meta-analysis of randomized controlled trialsTarek Haykal, Mahmoud Barbarawi, Yazan Zayed, et al.
Internal Medicine Journal|July 6, 2019
Extended duration of thromboprophylaxis for medically ill patients: a systematic review and meta-analysis of randomised controlled trialsYazan Zayed, Babikir Kheiri, Mahmoud Barbarawi, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 8, 2018
CYP2C19 pharmacogenetics versus standard of care dosing for selecting antiplatelet therapy in patients with coronary artery disease: A meta-analysis of randomized clinical trialsBabikir Kheiri, Mohammed Osman, Ahmed Abdalla, et al.
Journal of Thrombosis and Thrombolysis|December 5, 2018
Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trialsBabikir Kheiri, Mohammed Osman, Ahmed Abdalla, et al.
The Clinical Respiratory Journal|April 5, 2019
Triple versus dual inhaler therapy in moderate-to-severe COPD: A systematic review and meta-analysis of randomized controlled trialsYazan Zayed, Mahmoud Barbarawi, Babikir Kheiri, et al.
Journal of Thrombosis and Thrombolysis|December 5, 2018
Restrictive versus liberal red blood cell transfusion for cardiac surgery: a systematic review and meta-analysis of randomized controlled trialsBabikir Kheiri, Ahmed Abdalla, Mohammed Osman, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 27, 2022
Identification of a Germline Pyrin Variant in a Metastatic Melanoma Patient With Multiple Spontaneous Regressions and Immune-related Adverse EventsCameron J Oswalt, Rami N Al-Rohil, Bala Theivanthiran, et al.
Science Translational Medicine|November 23, 2022
Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti-PD-1 immunotherapyBalamayooran Theivanthiran, Nagendra Yarla, Tarek Haykal, et al.
Pageof 6